Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PH 80

Next Previous
Drug Profile

PH 80

Alternative Names: ORG 39479; PH-80; PH-80-M; PH80-PMD NS

Latest Information Update: 02 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pherin Pharmaceuticals
  • Developer Pherin Pharmaceuticals; VistaGen Therapeutics
  • Class Antidepressants; Antimigraines; Steroids
  • Mechanism of Action Neurotransmitter receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Hot flashes; Migraine; Premenstrual dysphoric disorder

Most Recent Events

  • 26 Nov 2025 Pharmacodynamics data from a preclinical trial released by VistaGen Therapeutics
  • 26 Nov 2025 Pharmacokinetics and pharmacodynamics data from a phase-IIa exploratory trial in Hot flashes released by VistaGen Therapeutics
  • 09 Jul 2024 PH 80 has patent protection in the European Union, Hong Kong and Japan for the treatment of Migraine prior to July 2024

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top